8-K: Clearwater Paper Reports Mixed Q2 Results Amidst Strategic Shift

Clearwater Paper's second quarter saw a net loss of $26 million despite a 12% increase in net sales, driven by a major maintenance outage and lower paperboard prices, while the company also announced the sale of its tissue business.

Summary

• Clearwater Paper reported a net loss of $26 million for the second quarter of 2024, a significant downturn compared to a net income of $30 million in the same period last year.
• Net sales increased by 12% to $586 million, primarily due to the acquisition of the Augusta paperboard facility.
• Adjusted EBITDA decreased to $35 million, down from $71 million in the second quarter of 2023, largely due to a $32 million impact from planned maintenance at the Lewiston facility.
• The company's paperboard segment saw a 23% increase in net sales to $334 million, but experienced an operating loss of $12 million.
• Paperboard sales volumes increased by 46% to 272,585 tons, but average selling prices decreased by 14% to $1,216 per ton.
• The consumer products segment reported flat net sales at $253 million, with operating income increasing to $27 million.
• Retail tissue volumes increased by 3% to 81,196 tons, while average selling prices decreased by 3% to $3,104 per ton.
• Clearwater Paper announced the sale of its consumer products division (tissue business) to Sofidel America Corp. for $1.06 billion, expected to close in the fourth quarter of 2024.
• The company plans to use the proceeds from the tissue business sale to reduce debt and focus on growing its paperboard business.

Sentiment

Score: 4

Explanation: The sentiment is moderately negative due to the significant net loss and decrease in EBITDA, despite positive developments such as increased sales and the strategic sale of the tissue business. The company faces challenges in paperboard pricing and integration of the Augusta facility.

Positives

• Net sales increased by 12% year-over-year, driven by the Augusta acquisition.
• Paperboard sales volumes increased significantly by 46% in the second quarter.
• The consumer products segment saw increased operating income and Adjusted EBITDA due to higher volumes and lower input costs.
• The company has secured a $1.06 billion sale of its tissue business, which will allow it to focus on paperboard.
• The company is on track with the integration of the Augusta paperboard facility.
• The company has maintained strong financial flexibility.

Negatives

• The company reported a net loss of $26 million in the second quarter, a significant decrease from the previous year's profit.
• Adjusted EBITDA decreased by $36 million year-over-year, primarily due to planned maintenance at the Lewiston facility.
• Paperboard average selling prices decreased by 14% year-over-year.
• The paperboard segment experienced an operating loss of $12 million.
• The company's net debt increased significantly to $1,117.6 million.

Risks

• The company faces risks related to the integration of the Augusta paperboard facility.
• Competitive pricing pressures and fluctuations in foreign currency could impact product pricing.
• Changes in the cost and availability of wood fiber and wood pulp could affect profitability.
• The company is exposed to risks related to manufacturing disruptions and cyber-security.
• The sale of the tissue business is subject to regulatory approval and other closing conditions, which may not be met.
• The company's ability to service its debt obligations is subject to debt covenants and terms.

Future Outlook

Clearwater Paper expects a gradual recovery in paperboard market demand for the remainder of 2024 and into 2025, and anticipates closing the sale of its tissue business in the fourth quarter of 2024. The company plans to use the proceeds to reduce debt and focus on growing its paperboard business.

Management Comments

• We completed the acquisition of the Augusta facility in May and our integration is on track.
• We are pleased with the quality of the assets and are committed to achieving our targeted synergies by the end of 2026.
• Our tissue business continues to deliver outstanding performance, and we are expecting a gradual recovery in paperboard market demand in the coming quarters.
• We thoroughly explored strategic options for our tissue business and believe that Sofidel will be well positioned to continue investing in these assets for long-term growth.
• This is a transformational time for Clearwater paper, and we are looking forward to the next chapter of value creation as we continue our strategy to scale and grow our paperboard business.

Industry Context

The announcement comes amid a broader trend of consumers shifting towards private brand products, particularly in the tissue segment, and a gradual recovery in the paperboard market. The sale of the tissue business and focus on paperboard aligns with industry trends towards specialization and strategic portfolio management.

Comparison to Industry Standards

• Clearwater Paper's paperboard sales volume increase of 46% is significant, but the 14% price decrease indicates potential competitive pressures or market softness compared to other paperboard producers.
• The company's tissue business is performing well with strong demand, which is consistent with the trend of increased private brand consumption, but the 3% price decrease may indicate competitive pressures.
• The planned major maintenance at the Lewiston facility, while impacting Q2 results, is a common practice in the industry, and the $32 million impact is within the range of similar maintenance events at other paper mills.
• The sale of the tissue business for $1.06 billion is a significant strategic move, and the valuation will be compared to similar transactions in the paper and packaging industry.
• The company's leverage ratio of 3.58x is a key metric that will be compared to industry benchmarks and peer companies such as WestRock and Packaging Corporation of America.

Stakeholder Impact

• Shareholders will be impacted by the net loss and decreased profitability in the short term, but may benefit from the strategic shift towards paperboard and debt reduction in the long term.
• Employees in the tissue division will be impacted by the sale of the business to Sofidel America Corp.
• Customers of the paperboard division may see improved product offerings and capacity.
• Suppliers may see changes in demand and purchasing patterns as the company focuses on paperboard.
• Creditors will be impacted by the company's increased debt levels and plans for debt reduction.

Next Steps

• The company will focus on integrating the Augusta paperboard facility.
• The company will work towards closing the sale of its tissue business in the fourth quarter of 2024.
• The company will use the proceeds from the tissue sale to reduce debt and grow its paperboard business.
• The company will continue to monitor and respond to market demand and pricing pressures.

Key Dates

Keywords

paperboard, tissue, acquisition, EBITDA, net sales, net loss, consumer products, maintenance, divestiture, debt, Augusta, Sofidel